Parent evaluation of spasticity treatment in cerebral palsy using botulinum toxin type A.
OBJECTIVE
To assess parent ratings of treatment acceptability associated with botulinum toxin type A (BTX-A) injection for spasticity in children with cerebral palsy (CP).


METHODS
A single-point survey design across a sequentially recruited cohort, using a standardized evaluation measure.


METHODS
Regional specialty health care center medical clinic and pain research program.


METHODS
Fifty-nine parents of children with CP receiving BTX-A injection for spasticity.


METHODS
Not applicable.


METHODS
The Treatment Evaluation Inventory.


RESULTS
Overall, parent ratings of treatment acceptability ranged from moderate to high. There were no significant differences for caregiver ratings in relation to characteristics of the raters (age, sex, marital status) or of the children (age, sex, mental retardation, severity of disability) characteristics.


CONCLUSIONS
These findings indicate that on average, parents of children with CP consider BTX-A treatment for the management of spasticity to be an acceptable form of treatment.
Symons
Frank J
FJ
Department of Educational Psychology, University of Minnesota, Minneapolis, MN 55455, USA. symon007@umn.edu
Rivard
Patrick F
PF
Nugent
Andrea C
AC
Tervo
Raymond C
RC
D000293:Adolescent; D000328:Adult; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D002547:Cerebral Palsy / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D010290:Parents; D017060:Patient Satisfaction; D011795:Surveys and Questionnaires
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A